Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI)

Cocchetti Carlotta; Castellini Giovanni; Iacuaniello Davide; Romani Alessia; Maggi Mario; Vignozzi Linda; Schreiner Thomas; den Heijer Martin; TSjoen Guy; Fisher Alessandra Daphne

首页> 外文期刊>The journal of sexual medicine >Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI)

【24h】

Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI)

机译：性别肯定的荷尔蒙治疗是否影响了跨性别人员30年的心血管风险？为期两年的欧洲学习（ENIGI）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Cardiovascular (CV) implications of long-term gender affirming hormonal treatment (GAHT) in transgender individuals still remain largely unknown.

机译：背景：变性人长期性别确认激素治疗（GAHT）对心血管（CV）的影响仍基本未知。

著录项

来源
《The journal of sexual medicine》 |2021年第4期|共9页
作者
Cocchetti Carlotta; Castellini Giovanni; Iacuaniello Davide; Romani Alessia; Maggi Mario; Vignozzi Linda; Schreiner Thomas; den Heijer Martin; TSjoen Guy; Fisher Alessandra Daphne;
展开▼
作者单位

Florence Univ Hosp Androl Womens Endocrinol &

Gender Incongruence Un Florence Italy;

Univ Florence Dept Hlth Sci Psychiat Unit Florence Italy;

Univ Federico II Napoli Dipartimento Med Clin &

Chirurg Sez Endocrinol Naples Italy;

Florence Univ Hosp Androl Womens Endocrinol &

Gender Incongruence Un Florence Italy;

Univ Florence Dept Expt &

Clin Biomed Sci Mario Serio Florence Italy;

Florence Univ Hosp Androl Womens Endocrinol &

Gender Incongruence Un Florence Italy;

Oslo Univ Hosp Dept Endocrinol Oslo Norway;

Vrije Univ Amsterdam Med Ctr Amsterdam Univ Med Ctr Dept Endocrinol Amsterdam Netherlands;

Ghent Univ Hosp Ctr Sexol &

Gender Dept Endocrinol Ghent Belgium;

Florence Univ Hosp Androl Womens Endocrinol &

Gender Incongruence Un Florence Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类性卫生;
关键词
Gender Affirming Hormonal Treatment; Transgender; Cardiovascular Risk; Lipid Profile;

机译：性别肯定荷尔蒙治疗;变性;心血管风险;脂质概况;

相似文献

外文文献
专利

1. Growth Hormone Treatment, Cardiovascular Risk and Autonomic Maturation in Children and Adolescents with Growth Hormone Deficiency or Born Small for Gestational Age [J] . Reiner Buchhorn, Christian Willaschek 儿科学期刊（英文） . 2020,第001期
2. Would male hormonal contraceptives affect cardiovascular risk? [J] . Michael Zitzmann 亚洲男性学杂志（英文版） . 2018,第002期
3. Homocysteine,hypertension,and risks of cardiovascular events and all-cause death in the Chinese elderly population:a prospective study [J] . Zhong-Ying ZHANG, Xiang GU, Zhe TANG, 老年心脏病学杂志（英文版） . 2021,第010期
4. Association of level of leisure-time physical activity with risks of all-cause mortality and cardiovascular disease in an elderly Chinese population: a prospective cohort study [J] . Hao ZHAO, Xue-Ning ZHANG, Zhan SHI, 老年心脏病学杂志（英文版） . 2020,第010期
5. Clustering of Cardiovascular Risk Factors and Diabetes:A Prospective Cohort Study on the Inner Mongolian Population in China [J] . WANG Ting Ting, LIN Bo, CUI Wen Xiu, 生物医学与环境科学（英文版） . 2018,第010期
6. Cardiovascular implications of gender-affirming hormone treatment in the transgender population [J] . Dutra Erika, Lee Julie, Torbati Tina, Maturitas: International Journal for the Study of the Climacteric . 2019,第期

机译：性别肯定激素治疗在变性人群中的心血管影响
7. Which US States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services [J] . Zaliznyak Michael, Jung Eric E., Bresee Catherine, The journal of sexual medicine . 2021,第2期

机译：美国国家医疗补助方案为转型患者的性别肯定的激素治疗和性别肯定的生殖器手术提供了哪些美国国家的覆盖范围？：一项国家审查，并进行了一项关于确认服务覆盖范围的患者体验的研究
8. Prevalence of Sexual Dysfunctions in Transgender Persons: Results from the ENIGI Follow-Up Study (vol 16, pg 2018, 2019) [J] . Becker-Hebly Inga The journal of sexual medicine . 2020,第4期

机译：跨性别人士性功能障碍的患病率：ENIGI随访研究的结果（第16卷2018年，2019年）
9. Early-life antibiotic use is associated with wheezing among children with high atopic risk: a prospective European study [C] . Wenjie Sun, Erik Svendsen, Johannes Forster, Annual conference of the International Society of Exposure Science . 2014

机译：欧洲性前瞻性研究表明，早期使用抗生素与特应性高风险儿童的喘息相关
10. Changes of aerobic fitness and cardiovascular disease risk factors in children: A two-year longitudinal study. [D] . Ahn, Bumsoo. 2011

机译：儿童有氧适应性和心血管疾病危险因素的变化：一项为期两年的纵向研究。
11. Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI) [O] . Imke Matthys, Justine Defreyne, Els Elaut, 2021

机译：性别肯定荷尔蒙治疗期间的正面和负面影响变化：欧洲网络对性别不一致调查（ENIGI）的结果
12. Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI) [O] . Imke Matthys, Justine Defreyne, Els Elaut, 2021

机译：性别肯定荷尔蒙治疗期间的正面和负面影响变化：欧洲网络对性别不一致调查（ENIGI）的结果
13. Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Section 34. Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study, 30-Year Follow-Up [R] . Kannel, W. B. , Wolf, P. A. , Garrison, R. J. 1987

机译：Framingham研究：心血管疾病的流行病学调查。第34节。使用汇总重复双年度测量与心血管疾病和死亡年发病率相关的一些风险因素：Framingham心脏研究，30年随访

Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI)

摘要

著录项

相似文献

相关主题

期刊订阅